Tanios Bekaii-Saab, MD, FACP

Following completing his undergraduate studies at McGill University in Montreal, Dr. Bekaii-Saab earned his medical degree from the American University of Beirut in Lebanon. This was followed by a residency in internal medicine at Indiana University Medical Center in Indianapolis, Indiana. He then completed fellowships in clinical pharmacology and experimental therapeutics and hematology/oncology at Tufts University/New England Medical Center in Boston, Massachusetts. Dr. Bekaii-Saab joined the faculty at the Mayo Clinic in May 2016 as Co-Leader of the Enterprise wide Gastrointestinal Cancer Program at the Mayo Clinic Cancer Center and Professor at the Mayo Clinic College of Medicine and Science. He is also a Senior Associate Consultant, Division of Hematology and Oncology in Mayo Clinic Arizona. He was previously at the Ohio State University – Arthur G. James Cancer Hospital and Solove Research Institute as a tenured Professor of Medicine and Pharmacy, and Section Chief for the Gastrointestinal Cancer...

CCF meets with CASCAP and The Cholangiocarcinoma Foundation of Thailand

From our friends at CASCAP … CASCAP and together with The Cholangiocarcinoma Foundation of Thailand hosted a meeting with Prof. John Bridgewater University of London, Stacie Lindsey , President, Cholangiocarcinoma Foundation USA, Prof. Milind Javle M.D., Tenure Track, Department of Gastrointestinal (GI) Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX . Vice Chair of the Cholangiocarcinoma Foundation USA, Asst. Prof. Dr. Yun Shin Chun M.D., Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX. Dr. Mitesh J. Borad, M.D. Mayo Clinic, Department of Oncology, Phoenix, Arizona, Sean Tuberville Board member, Cholangiocarcinoma Foundation USA., and Patty Maxin, Patient Advocate, Cholangiocarcinoma Foundation USA.   This first meeting with our US counterparts will greatly help to further establish and grow a very important global alliance to combat CCA. We greatly appreciate our friends from US and...

Immunotherapy of Cholangiocarcinoma

Study Name   Immunotherapy of cholangiocarcinoma ClinicalTrials.gov Identifier (if applicable)   https://clinicaltrials.gov/ct2/show/NCT03042182 Study Center Institution Name   Immunitor LLC Institution Address   25 peace Avenue City   Ulaanbaatar State   New York Zip Code   14400 Phone   (301) 476-0930 Website   http://www.immunitor.com Study Contacts Principal Investigator   Aldar Bourinbaiar P.I. Phone   (301) 476-0930 P.I. Email   immunitor@gmail.com Study Coordinator   Immunitor LLC Study Coordinator Phone   (917) 326-9508 Study Coordinator Email   info@immunitor.com List additional Study Coordinators (include phone number and email)   Study will be conducted in Mongolia, but those who are interested to join can apply for exemption OVERVIEW – in layman’s terms (150 words max)   Earlier version of immunotherapy, which was designed for patients with hepatocellular carcinoma (HCC) has shown limited efficacy in patients with cholangiocarcinoma (CCA). The decline in levels of CA19.9 marker common in CCA correlated with tumor shrinkage. Enrollment  ...

Andrea’s Night 2017

Andrea’s Night “On the 50 Yard Line” was held on January 14, 2017 in Evansville, IN, by Dan Fuquay and Andrea Remembered in memory of Andrea Fuquay.  This annual event was once again a huge success with a sold-out crowd of 500 attendees!  The fundraiser cleared $110,000 for distribution to various charities including the Cholangiocarcinoma Foundation, which received $30,000. Thank...

Pin It on Pinterest